Tamoxifen instigates uterine cancer development by activating PI3K signaling and supersedes PIK3CA driver mutations

被引：1
|
作者：
Kubler, Kirsten
Nardone, Agostina
Anand, Shankara
Gorvich, Daniel
Droog, Marjolein
Hermida-Prado, Francisco
Akshi, Tara
Feit, Avery S.
Cohen, Gabriella
Dackus, Gwen
Pun, Matthew
Kuang, Yanan
Cha, Justin
Miller, Mendy
Gibson, William J.
Paweletz, Cloud P.
Van Allen, Eliezer M.
van Leeuwen, Flora E.
Nederlof, Petra
Hollema, Harry
Quang-De Nguyen
Mourits, Marian J. E.
Leshchiner, Ignaty
Stewart, Chip
Matulonis, Ursula A.
Zwart, Wilbert
Maruvka, Yosef E.
Getz, Gad
Jeselsohn, Rinath
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS21-GS2-09
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
GS2-09
引用
收藏
页数：2
相关论文
共 50 条
  • [21] PIK3CA Mutations in Patients with Advanced Cancers Treated with PI3K/AKT/mTOR Axis Inhibitors
    Janku, Filip
    Tsimberidou, Apostolia M.
    Garrido-Laguna, Ignacio
    Wang, Xuemei
    Luthra, Rajyalakshmi
    Hong, David S.
    Naing, Aung
    Falchook, Gerald S.
    Moroney, John W.
    Piha-Paul, Sarina A.
    Wheler, Jennifer J.
    Moulder, Stacy L.
    Fu, Siqing
    Kurzrock, Razelle
    MOLECULAR CANCER THERAPEUTICS, 2011, 10 (03) : 558 - 565
  • [22] Comparative molecular dynamics analyses on PIK3CA hotspot mutations with PI3Kα specific inhibitors and ATP
    Mentes, Muratcan
    Karakuzulu, Basak Buse
    Ucar, Gonlum Bahar
    Yandim, Cihangir
    COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2022, 99
  • [23] PIK3Ca mutations in prostate cancer
    Agell, Laia
    Hernandez, Silvia
    de Muga, Silvia
    Lorente, Jose Antonio
    Juanpere, Nuria
    Esgueva, Raquel
    Gelabert, Antoni
    Serrano, Sergi
    Lloreta, Josep
    VIRCHOWS ARCHIV, 2008, 452 : S26 - S27
  • [24] PI3K/AKT/mTOR Inhibitors in Patients With Breast and Gynecologic Malignancies Harboring PIK3CA Mutations
    Janku, Filip
    Wheler, Jennifer J.
    Westin, Shannon N.
    Moulder, Stacy L.
    Naing, Aung
    Tsimberidou, Apostolia M.
    Fu, Siqing
    Falchook, Gerald S.
    Hong, David S.
    Garrido-Laguna, Ignacio
    Luthra, Rajyalakshmi
    Lee, J. Jack
    Lu, Karen H.
    Kurzrock, Razelle
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (08) : 777 - 782
  • [25] Targeting the PI3K signaling cascade in PIK3CA mutated endometrial cancer in a primary human xenograft model.
    Bradford, Leslie Siriya
    Rauh-Hain, Jose Alejandro
    Clark, Rachel Marie
    Groeneweg, Jolijn W.
    Zhang, Ling
    DiGloria, Celeste M.
    Borger, Darrell R.
    Growdon, Whitfield Board
    Schorge, John O.
    Foster, Rosemary
    Rueda, Bo R.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [26] PIK3CA regulates development of diabetes retinopathy through the PI3K/Akt/mTOR pathway
    Guan, Ruijuan
    Kang, Zefeng
    Li, Ling
    Yan, Xin
    Gao, Tianpeng
    PLOS ONE, 2024, 19 (01):
  • [27] Understanding PI3K/Akt/mTOR signaling in squamous cell carcinoma: mutated PIK3CA as an example
    Zheng, Shutao
    He, Shuo
    Liang, Yan
    Tan, Yiyi
    Liu, Qing
    Liu, Tao
    Lu, Xiaomei
    MOLECULAR BIOMEDICINE, 2024, 5 (01):
  • [28] Selective PI3K inhibition in wild type and PIK3CA mutated human gastrointestinal cancer
    Mueller, A.
    Bachmann, E.
    Linnig, M.
    Khillimberger, K.
    Galle, P. R.
    Moehler, M.
    ONKOLOGIE, 2011, 34 : 246 - 246
  • [29] Frequent PIK3CA activating mutations in nipple adenomas
    Liau, Jau-Yu
    Lee, Yi-Hsuan
    Tsai, Jia-Huei
    Yuan, Chang-Tsu
    Chu, Chia-Yu
    Hong, Jin-Bon
    Sheen, Yi-Shuan
    HISTOPATHOLOGY, 2017, 70 (02) : 195 - 202
  • [30] PIK3CA Activating Mutations in Facial Infiltrating Lipomatosis
    Maclellan, Reid A.
    Luks, Valerie L.
    Vivero, Matthew P.
    Mulliken, John B.
    Zurakowski, David
    Padwa, Bonnie L.
    Warman, Matthew L.
    Greene, Arin K.
    Kurek, Kyle C.
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2014, 133 (01) : 12E - 19E
12345